Salehi noted that in the clinical trials, depending on the drug, only about five to ten percent of patients stopped using them, but when you go to the real-world studies, almost actually 50 percent of people, they stop these drugs by six months to 12 months. Salehi explained that its unclear if that is because of the side effects, though they could be playing a role
To comprehensively evaluate the therapeutic effects of semaglutide on hepatic steatosis, future studies should incorporate complementary methods such as Oil Red O staining (Zhu et al., 2019), biochemical hepatic TG assays (Rong et al., 2024), or non-invasive imaging techniques such as magnetic resonance imaging with proton density fat fraction (MRI-PDFF) (Park et al., 2022)
If certain foods upset your stomach, like ones with strong smells, fizzy drinks or dairy, its best to skip them
02 In the international market, NA-931 not only addresses the demand for safe and effective weight-loss medications among obese patients but also provides governments and healthcare institutions worldwide with a powerful tool to tackle obesity as a global public health challenge